(Total Views: 266)
Posted On: 10/10/2018 8:49:09 PM
Post# of 72436
![Avatar](https://investorshangout.com/images/ProfileImages/1207987678_3042_Picture 5.jpg)
Priority Review could/would be used in the advancement of B-OM without issuing a "voucher" as the drug itself is what is receiving the priority review and not an "award" after getting the drug approved.
Kelt
Kelt
![](/m/images/thumb-up.png)
![](/m/images/thumb-down.png)